How long does it take to see the effect of Tilpotide/Mufenda?

Tirzepatide is a new type of dual-action receptor agonist that can activate both the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor, so it is called the "first dual-target peptide drug". This unique mechanism of action allows it to improve blood sugar control in patients with type 2 diabetes while also having a positive impact on weight management.

From a pharmacological mechanism perspective, tilpotide takes effect within weeks of initiating treatment. It can improve postprandial blood sugar fluctuations in the short term by stimulating insulin secretion, inhibiting glucagon release, and delaying gastric emptying. Some patients can observe a downward trend in blood sugar levels after one to two weeks of use. As the treatment time prolongs, blood sugar control will gradually stabilize. Usually, after four to twelve weeks of regular use, patients can see more significant effects, and changes in weight will gradually appear. It should be pointed out that the specific effect time varies depending on individual differences, including the patient's basal blood sugar level, body mass index, whether combined with other anti-diabetic drugs, and lifestyle factors.

In clinical practice, doctors usually start with a low dose and gradually adjust to an appropriate dose to reduce the occurrence of early adverse reactions. At this time, patients should not rashly stop the drug or increase the dose because the short-term effect is not obvious, but should wait patiently according to the doctor's guidance, because the effect of tilpotide is a gradual process. Improvements in blood sugar control often precede weight loss, and weight changes take longer to manifest.

It is worth noting that tilpotide does not only pursue short-term effects, but also long-term blood sugar management and reduction of the risk of complications. Studies have shown that long-term use of the drug can significantly improve glycosylated hemoglobin levels and reduce cardiovascular risk factors. Therefore, a reasonable expectation for patients is that they will feel an improvement in blood sugar initially, but it will take several months of continued treatment to see the full benefits of weight control and metabolic improvements.

Reference materials:https://www.drugs.com/tirzepatide.html